Ellipsis Health

Ellipsis Health builds AI-driven technology for mental healthcare. Its work spans several technical areas: patented vocal biomarker technology, speech acoustics analysis, conversational artificial intelligence, and natural language processing and semantics analysis. The stated purpose is to help healthcare organisations deliver scalable, empathetic care management, with clinical research and real-world validation as the basis for its methods.

The company's product, Sage, is described as a HIPAA-compliant AI Care Manager intended for use across the whole patient journey. It combines the firm's vocal biomarker technology with conversational AI, and is designed to detect signs of depression and anxiety. Ellipsis Health positions Sage as the world's most emotionally intelligent AI Care Manager, delivering care management 24/7 and at scale.

Its customers are leading health plans, health systems and specialty care organisations across the United States, the company's sole listed market. The relevant industry verticals are healthcare and behavioural health, spanning payers, providers and specialty care.

Internally, the company emphasises clinical rigour, improved patient outcomes, reduced administrative burden for healthcare teams, and equity and access for underserved populations.